Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY).
Share price
Name
0.00
0 SEK (0%)
HH:MM CET • 20YY-MM-DD
Latest presentations
Find your topic of interest
American Depositary Receipt
Analyst reports
Investment thesis
Latest CEO Comments
NOVEMBER 4, 2020
"Keeping focus and maximizing business opportunities in a challenging environment"
Read the latest CEO comments from Nikolaj Sørensen
News flow
Press Releases and News
Orexo’s Partner Gesynta Pharma Initiates Phase II Study of OX-MPI in Systemic Sclerosis
Invitation to presentation of Orexo´s Full Year Report 2020, incl. Q4, on January 28 at 2 pm CET
Orexo announces new US patent for ZUBSOLV®
Orexo Enters Exclusive License and Supply Agreement with Accord Healthcare for ZUBSOLV[® ]in Europe
Key financial figures
Group net revenue
742 MSEK
Last Twelve Months, Q419-Q320
Group EBITDA
104 MSEK
Last Twelve Months, Q419-Q320
US Pharma segment EBIT
331 MSEK
Last Twelve Months, Q419-Q320
Cash position
593 MSEK
Q320
